Everyone hopes and wishes for that last-minute cancer breakthrough that will save doomed patients. It almost never actually happens. With Gleevec, it did.Read more here.
The once-a-day pill turned chronic myelogenous leukemia, or CML, from a certain death sentence into a manageable disease. Now data shows it's helped 83 percent of patients live 10 years or longer, even with side-effects that include a characteristic rash, nausea and fatigue.
Friday, March 10, 2017
A miracle drug!
Glenn Reynolds links to an article by Maggie Fox at NBC News.